We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RFL icon
12101
CALL
Rafael Holdings
RFL
$103M
$31K ﹤0.01%
+16,630
New +$33.1K
SCYX icon
12102
PUT
SCYNEXIS
SCYX
$51.5M
$31K ﹤0.01%
2,088
+425
+26% +$8.18K
TRUE
12103
DELISTED
TrueCar
TRUE
$31K ﹤0.01%
11,878
-287,261
-96% -$952K
USIO icon
12104
CALL
Usio Inc
USIO
$78.6M
$31K ﹤0.01%
12,800
-19,000
-60% -$50.3K
VRCA icon
12105
PUT
Verrica Pharmaceuticals
VRCA
$85.4M
$31K ﹤0.01%
+1,620
New +$81.4K
XFOR icon
12106
PUT
X4 Pharmaceuticals
XFOR
$418M
$31K ﹤0.01%
1,073
-1,040
-49% -$39.6K
FAASW
12107
DELISTED
DigiAsia Corp Warrant
FAASW
$31K ﹤0.01%
617,791
-213,957
-26% -$30.9K
QNTM
12108
CALL
Quantum Biopharma Class B Subordinate Voting Shares
QNTM
$24.4M
$31K ﹤0.01%
611
-597
-49% -$35.8K
MKFG.WS
12109
DELISTED
Markforged Holding Corporation Warrants, each whole warrant exercisable to purchase one-tenth (1/10th) of a share of Common Stock at an exercise price of $115.00 per share
MKFG.WS
$31K ﹤0.01%
99,749
-1,931
-2% -$842
KA
12110
DELISTED
Kineta, Inc. Common Stock
KA
$31K ﹤0.01%
2,440
+283
+13% +$2.72K
GMDA
12111
CALL
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$31K ﹤0.01%
17,500
-39,000
-69% -$99.1K
MDVL
12112
DELISTED
MedAvail Holdings, Inc. Common Stock
MDVL
$31K ﹤0.01%
+403
New +$35.4K
DMK
12113
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$31K ﹤0.01%
897
+34
+4% +$1.06K
YVR
12114
CALL
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
$31K ﹤0.01%
20,100
+11,325
+129% +$22.8K
CDAK
12115
CALL
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$31K ﹤0.01%
+10,600
New +$37.2K
SLCRW
12116
DELISTED
Silver Crest Acquisition Corporation Warrant
SLCRW
$31K ﹤0.01%
145,172
-200,100
-58% -$63.1K
AXDX
12117
CALL
DELISTED
Accelerate Diagnostics
AXDX
$30K ﹤0.01%
2,990
+1,760
+143% +$15.6K
STEX
12118
CALL
Streamex Corp
STEX
$108M
$30K ﹤0.01%
4,540
+270
+6% +$2.54K
CGEN icon
12119
PUT
Compugen
CGEN
$228M
$30K ﹤0.01%
+16,200
New +$35K
DOYU
12120
PUT
DouYu International Holdings
DOYU
$142M
$30K ﹤0.01%
2,520
-1,280
-34% -$19.6K
EBON icon
12121
Ebang International Holdings
EBON
$12.7M
$30K ﹤0.01%
2,476
+1,731
+232% +$42.3K
EVGN icon
12122
CALL
Evogene
EVGN
$9.49M
$30K ﹤0.01%
3,880
+2,560
+194% +$25K
HCTI icon
12123
Healthcare Triangle
HCTI
$2.45M
0
LSF icon
12124
Laird Superfood
LSF
$52.7M
$30K ﹤0.01%
15,697
-4,980
-24% -$13.6K
PHUN icon
12125
PUT
Phunware
PHUN
$42.8M
$30K ﹤0.01%
552
-1,012
-65% -$84.6K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.